|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases oxidation |
ISO |
CYP1A1 protein results in increased oxidation of biphenyl |
CTD |
PMID:27137136 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity increases oxidation |
ISO |
biphenyl results in decreased activity of CYP1A2 protein CYP1A2 protein results in increased oxidation of biphenyl |
CTD |
PMID:15916432 PMID:27137136 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
biphenyl binds to and results in decreased activity of CYP1B1 protein |
CTD |
PMID:19563207 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
affects binding increases oxidation |
ISO |
biphenyl binds to CYP2A13 protein CYP2A13 protein results in increased oxidation of biphenyl |
CTD |
PMID:27137136 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases activity |
ISO |
biphenyl results in decreased activity of ESR1 protein |
CTD |
PMID:22562034 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO |
biphenyl results in increased activity of NR1I3 protein |
CTD |
PMID:28927721 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
|
G |
Ar |
androgen receptor |
decreases activity multiple interactions |
ISO |
2-phenylphenol results in decreased activity of AR protein 2-phenylphenol inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; Dihydrotestosterone inhibits the reaction [2-phenylphenol results in increased activity of AR protein] |
CTD |
PMID:15064155 PMID:18294747 PMID:21310686 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
CAT protein inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene]; CAT protein inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of TP53 gene] |
CTD |
PMID:10334203 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
2-phenylphenol results in increased expression of CYP1A1 mRNA |
CTD |
PMID:23665931 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
affects binding |
ISO |
2-phenylphenol binds to CYP1A2 protein |
CTD |
PMID:32278787 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression affects binding increases expression |
ISO |
2-phenylphenol results in decreased expression of ESR1 mRNA 2-phenylphenol binds to ESR1 protein 2-phenylphenol results in increased expression of ESR1 mRNA |
CTD |
PMID:12598185 PMID:12737316 PMID:12822488 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases expression |
ISO |
2-phenylphenol results in increased expression of ESR2 mRNA |
CTD |
PMID:12737316 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
affects binding |
ISO |
2-phenylphenol binds to FLT1 protein |
CTD |
PMID:32278787 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Hexb |
hexosaminidase subunit beta |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [2-phenylphenol results in increased secretion of HEXB protein] |
CTD |
PMID:15272608 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
ISO |
[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene; bathocuproine inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene]; CAT protein inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene] |
CTD |
PMID:10334203 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
affects binding |
ISO |
2-phenylphenol binds to MMP9 protein |
CTD |
PMID:32278787 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
2-phenylphenol binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:21115097 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO |
2-phenylphenol results in increased activity of NR1I3 protein |
CTD |
PMID:28927721 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Orm1 |
orosomucoid 1 |
increases expression |
ISO |
2-phenylphenol results in increased expression of ORM1 protein |
CTD |
PMID:20025956 |
|
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
|
|
G |
Pgr |
progesterone receptor |
increases expression |
ISO |
2-phenylphenol results in increased expression of PGR mRNA |
CTD |
PMID:12822488 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Phex |
phosphate regulating endopeptidase X-linked |
increases expression |
ISO |
2-phenylphenol results in increased expression of PHEX protein |
CTD |
PMID:20025956 |
|
NCBI chr X:37,607,553...37,856,183
Ensembl chr X:37,610,760...37,854,469
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[2-phenylphenol binds to and results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of and results in decreased secretion of Prostaglandin D2 |
CTD |
PMID:26359731 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Serpinb5 |
serpin family B member 5 |
affects binding |
ISO |
2-phenylphenol binds to SERPINB5 protein |
CTD |
PMID:32278787 |
|
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
|
|
G |
Thrb |
thyroid hormone receptor beta |
affects binding |
ISO |
2-phenylphenol binds to THRB protein |
CTD |
PMID:32278787 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of TP53 gene; bathocuproine inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of TP53 gene]; CAT protein inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of TP53 gene] |
CTD |
PMID:10334203 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Ugt2b15 |
UDP glucuronosyltransferase family 2 member B15 |
increases metabolic processing |
EXP |
UGT2B15 protein results in increased metabolism of 2-phenylphenol |
CTD |
PMID:7574722 |
|
NCBI chr14:20,768,015...20,783,599
Ensembl chr14:20,768,015...20,783,589
|
|
G |
Vdr |
vitamin D receptor |
affects binding |
ISO |
2-phenylphenol binds to VDR protein |
CTD |
PMID:32278787 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
2-phenylphenol results in increased expression of VEGFA protein |
CTD |
PMID:20025956 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Ar |
androgen receptor |
affects binding |
ISO |
4,4'-dihydroxybiphenyl binds to AR protein |
CTD |
PMID:12161000 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding |
ISO |
4,4'-dihydroxybiphenyl binds to ESR1 protein |
CTD |
PMID:12161000 PMID:12753421 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[4,4'-dihydroxybiphenyl co-treated with Lipopolysaccharides] results in increased expression of PTGS2 |
CTD |
PMID:19528508 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
|
G |
Alb |
albumin |
affects binding |
ISO |
4-biphenylamine binds to ALB protein |
CTD |
PMID:11697451 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Blm |
BLM RecQ like helicase |
multiple interactions decreases expression |
ISO |
TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of BLM mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression multiple interactions |
ISO |
4-biphenylamine results in decreased expression of BRCA1 mRNA TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of BRCA1 mRNA] |
CTD |
PMID:24857880 PMID:32905825 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brcc3 |
BRCA1/BRCA2-containing complex subunit 3 |
multiple interactions decreases expression |
ISO |
TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of BRCC3 mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr 9:1,986,942...1,989,484
Ensembl chr 9:1,986,575...1,991,080
|
|
G |
Ccnd3 |
cyclin D3 |
multiple interactions decreases expression |
ISO |
TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of CCND3 mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccne2 |
cyclin E2 |
decreases expression multiple interactions |
ISO |
4-biphenylamine results in decreased expression of CCNE2 mRNA TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of CCNE2 mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression multiple interactions |
ISO |
4-biphenylamine results in decreased expression of CDK1 mRNA TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of CDK1 mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression multiple interactions |
ISO |
4-biphenylamine results in decreased expression of CDK2 mRNA TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of CDK2 mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO |
TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of CDKN1A mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Chek1 |
checkpoint kinase 1 |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of CHEK1 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of CIDEA mRNA |
CTD |
PMID:24857880 |
|
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
increases expression multiple interactions |
ISO |
4-biphenylamine results in increased expression of CREB1 protein Acetylcysteine inhibits the reaction [4-biphenylamine results in increased expression of CREB1 protein]; CREB1 protein affects the reaction [4-biphenylamine results in increased expression of MIR630 mRNA] |
CTD |
PMID:32433928 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases oxidation |
EXP |
CYP1A1 protein results in increased oxidation of 4-biphenylamine |
CTD |
PMID:2908851 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity increases oxidation multiple interactions increases metabolic processing affects metabolic processing |
ISO EXP |
CYP1A2 protein results in increased activity of 4-biphenylamine CYP1A2 protein results in increased oxidation of 4-biphenylamine [furafylline results in decreased activity of CYP1A2 protein] which results in decreased susceptibility to 4-biphenylamine; CYP1A2 protein results in increased hydroxylation of and results in increased activity of 4-biphenylamine CYP1A2 protein results in increased metabolism of 4-biphenylamine CYP1A2 protein affects the metabolism of 4-biphenylamine |
CTD |
PMID:2655891 PMID:2908851 PMID:11376689 PMID:15450435 PMID:16988941 PMID:23898916 More...
|
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
CYP2A13 protein results in increased hydroxylation of and results in increased activity of 4-biphenylamine |
CTD |
PMID:16988941 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases oxidation |
EXP |
CYP2B1 protein results in increased oxidation of 4-biphenylamine |
CTD |
PMID:2908851 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases hydroxylation increases expression multiple interactions decreases response to substance |
ISO |
CYP2E1 protein results in increased hydroxylation of 4-biphenylamine 4-biphenylamine results in increased expression of CYP2E1 protein [Propolis co-treated with allyl sulfide] inhibits the reaction [4-biphenylamine results in increased expression of CYP2E1 protein]; allyl sulfide inhibits the reaction [4-biphenylamine results in increased expression of CYP2E1 protein]; Propolis inhibits the reaction [4-biphenylamine results in increased expression of CYP2E1 protein] [CYP2E1 protein results in increased hydroxylation of 4-biphenylamine] which results in increased abundance of Reactive Oxygen Species CYP2E1 gene mutant form results in decreased susceptibility to 4-biphenylamine |
CTD |
PMID:25601990 PMID:33847444 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
increases reduction |
ISO |
CYP2S1 protein results in increased reduction of 4-biphenylamine analog |
CTD |
PMID:23682735 |
|
NCBI chr 1:81,309,948...81,325,303
Ensembl chr 1:81,310,451...81,325,303
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
4-biphenylamine results in increased expression of DDIT3 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Exo1 |
exonuclease 1 |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of EXO1 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
|
|
G |
Fancg |
FA complementation group G |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of FANCG mRNA; 4-biphenylamine results in decreased expression of FANCG protein |
CTD |
PMID:24857880 |
|
NCBI chr 5:57,230,287...57,240,067
Ensembl chr 5:57,231,685...57,240,029
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
decreases expression multiple interactions |
ISO |
4-biphenylamine results in decreased expression of FEN1 mRNA TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of FEN1 mRNA] |
CTD |
PMID:24857880 PMID:32905825 |
|
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
increases expression |
ISO |
4-biphenylamine results in increased expression of GADD45G mRNA |
CTD |
PMID:24857880 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [4-biphenylamine results in increased expression of H2AX protein]; Propolis inhibits the reaction [4-biphenylamine results in increased expression of H2AX protein]; TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of H2AX protein] |
CTD |
PMID:32433928 PMID:32905825 PMID:33847444 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
H3f4 |
H3.4 histone, cluster member |
decreases methylation multiple interactions |
ISO |
4-biphenylamine results in decreased methylation of H3-4 protein [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 4-biphenylamine co-treated with Benzo(a)pyrene co-treated with Tetrachlorodibenzodioxin] results in decreased methylation of H3-4 protein |
CTD |
PMID:17468514 |
|
NCBI chr10:43,740,702...43,741,262
|
|
G |
Hdac2 |
histone deacetylase 2 |
decreases expression multiple interactions |
ISO |
4-biphenylamine results in decreased expression of HDAC2 mRNA TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of HDAC2 mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
multiple interactions |
ISO |
[NAT1 polymorphism results in increased susceptibility to 4-biphenylamine] which results in increased mutagenesis of HPRT1 gene; NAT2 polymorphism affects the reaction [4-biphenylamine results in increased mutagenesis of HPRT1 gene] |
CTD |
PMID:22114069 PMID:36040704 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
increases mutagenesis |
ISO |
4-biphenylamine results in increased mutagenesis of HRAS gene |
CTD |
PMID:15761837 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Il6 |
interleukin 6 |
increases expression |
ISO |
4-biphenylamine results in increased expression of IL6 protein |
CTD |
PMID:27746196 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ip6k3 |
inositol hexakisphosphate kinase 3 |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of IP6K3 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr20:5,223,863...5,245,443
Ensembl chr20:5,224,120...5,245,428
|
|
G |
Kdm1a |
lysine demethylase 1A |
multiple interactions |
ISO |
[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 4-biphenylamine co-treated with Benzo(a)pyrene] affects the localization of KDM1A protein |
CTD |
PMID:17468514 |
|
NCBI chr 5:148,782,976...148,838,319
Ensembl chr 5:148,782,976...148,838,319
|
|
G |
Lig1 |
DNA ligase 1 |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of LIG1 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413
|
|
G |
Lig4 |
DNA ligase 4 |
increases expression multiple interactions |
ISO |
4-biphenylamine results in increased expression of LIG4 mRNA TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of LIG4 mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr16:79,518,393...79,526,956
Ensembl chr16:79,518,312...79,527,040
|
|
G |
Mcm8 |
minichromosome maintenance 8 homologous recombination repair factor |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [4-biphenylamine results in decreased expression of MCM8 protein] |
CTD |
PMID:32433928 |
|
NCBI chr 3:120,086,741...120,117,008
Ensembl chr 3:120,086,763...120,117,008
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
increases expression multiple interactions |
ISO |
4-biphenylamine results in increased expression of MDM2 mRNA TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of MDM2 mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mir17 |
microRNA 17 |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR17 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr15:92,180,629...92,180,712
Ensembl chr15:92,180,629...92,180,712
|
|
G |
Mir18a |
microRNA 18a |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR18A mRNA |
CTD |
PMID:24857880 |
|
NCBI chr15:92,180,765...92,180,860
Ensembl chr15:92,180,765...92,180,860
|
|
G |
Mir20b |
microRNA 20b |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR20B mRNA |
CTD |
PMID:24857880 |
|
NCBI chr X:132,422,211...132,422,282
Ensembl chr X:132,422,211...132,422,282
|
|
G |
Mir21 |
microRNA 21 |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR21 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir22 |
microRNA 22 |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR22 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr10:60,307,039...60,307,133
Ensembl chr10:60,307,039...60,307,133
|
|
G |
Mir295-1 |
microRNA 295-1 |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR372 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 1:65,962,566...65,962,646
Ensembl chr 1:65,962,566...65,962,646
|
|
G |
Mir29a |
microRNA 29a |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR29A mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 4:59,650,608...59,650,695
|
|
G |
Mir320a |
microRNA 320a |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR320A mRNA |
CTD |
PMID:24857880 |
|
NCBI chr15:45,516,392...45,516,473
Ensembl chr15:45,516,392...45,516,473
|
|
G |
Mir340-1 |
microRNA 340-1 |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR340 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr10:34,393,568...34,393,665
Ensembl chr10:34,393,568...34,393,665
|
|
G |
Mir425 |
microRNA 425 |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR425 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 8:109,264,555...109,264,637
Ensembl chr 8:109,264,555...109,264,637
|
|
G |
Mir431 |
microRNA 431 |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR431 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 6:128,544,210...128,544,323
Ensembl chr 6:128,544,210...128,544,323
|
|
G |
Mir494 |
microRNA 494 |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR494 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
|
|
G |
Mir7-1 |
microRNA 7-1 |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR7-1 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr17:6,273,264...6,273,360
Ensembl chr17:6,273,264...6,273,360
|
|
G |
Mir874 |
microRNA 874 |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR874 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr17:6,620,649...6,620,724
Ensembl chr17:6,620,649...6,620,724
|
|
G |
Mir93 |
microRNA 93 |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIR93 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr12:17,043,135...17,043,221
Ensembl chr12:17,043,135...17,043,221
|
|
G |
Mirlet7b |
microRNA let-7b |
increases expression |
ISO |
4-biphenylamine results in increased expression of MIRLET7B mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 7:116,804,186...116,804,270
Ensembl chr 7:116,804,186...116,804,270
|
|
G |
Mpo |
myeloperoxidase |
affects metabolic processing |
ISO |
MPO protein affects the metabolism of 4-biphenylamine |
CTD |
PMID:9288889 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Msh2 |
mutS homolog 2 |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of MSH2 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Nat1 |
N-acetyltransferase 1 |
increases activity increases metabolic processing increases acetylation multiple interactions increases response to substance affects response to substance |
ISO |
NAT1 protein results in increased activity of 4-biphenylamine NAT1 protein results in increased metabolism of 4-biphenylamine NAT1 protein polymorphism results in increased acetylation of 4-biphenylamine; NAT1 protein results in increased acetylation of 4-biphenylamine [NAT1 polymorphism results in increased susceptibility to 4-biphenylamine] which results in increased mutagenesis of HPRT1 gene NAT1 polymorphism results in increased susceptibility to 4-biphenylamine; NAT1 protein polymorphism results in increased susceptibility to 4-biphenylamine NAT1 mRNA alternative form affects the susceptibility to 4-biphenylamine |
CTD |
PMID:12088197 PMID:15450435 PMID:16815960 PMID:21837760 PMID:22010219 PMID:22114069 More...
|
|
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Nat2 |
N-acetyltransferase 2 |
increases acetylation multiple interactions increases metabolic processing affects response to substance decreases activity increases activity |
ISO EXP |
NAT2 protein results in increased acetylation of 4-biphenylamine NAT2 polymorphism affects the reaction [4-biphenylamine results in increased mutagenesis of HPRT1 gene] NAT2 protein results in increased metabolism of 4-biphenylamine NAT2 gene polymorphism affects the susceptibility to 4-biphenylamine 4-biphenylamine results in decreased activity of NAT2 protein 4-biphenylamine inhibits the reaction [NAT2 protein results in increased acetylation of 2-aminofluorene]; 4-biphenylamine inhibits the reaction [NAT2 protein results in increased acetylation of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine]; 4-biphenylamine inhibits the reaction [NAT2 protein results in increased acetylation of 4-Aminobenzoic Acid]; 4-biphenylamine inhibits the reaction [NAT2 protein results in increased acetylation of 4-biphenylamine] NAT2 protein results in increased activity of 4-biphenylamine |
CTD |
PMID:12222688 PMID:15450435 PMID:16815960 PMID:16857729 PMID:18842621 PMID:29180287 PMID:33136180 PMID:36040704 More...
|
|
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
4-biphenylamine results in increased expression of and affects the localization of NFE2L2 protein |
CTD |
PMID:25601990 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
decreases expression multiple interactions |
ISO |
4-biphenylamine results in decreased expression of OGG1 mRNA; 4-biphenylamine results in decreased expression of OGG1 protein Propolis inhibits the reaction [4-biphenylamine results in decreased expression of OGG1 protein] |
CTD |
PMID:16112689 PMID:33847444 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of PCNA mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pold3 |
DNA polymerase delta 3, accessory subunit |
decreases expression multiple interactions |
ISO |
4-biphenylamine results in decreased expression of POLD3 mRNA TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of POLD3 mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr 1:154,417,893...154,456,687
Ensembl chr 1:154,418,084...154,456,665
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
decreases expression multiple interactions |
ISO |
4-biphenylamine results in decreased expression of PRKDC mRNA TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of PRKDC mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
increases metabolic processing |
ISO |
PTGS1 protein results in increased metabolism of 4-biphenylamine |
CTD |
PMID:11159734 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases metabolic processing |
ISO |
PTGS2 protein results in increased metabolism of 4-biphenylamine |
CTD |
PMID:11159734 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rad18 |
RAD18 E3 ubiquitin protein ligase |
decreases expression multiple interactions |
ISO |
4-biphenylamine results in decreased expression of RAD18 mRNA; 4-biphenylamine results in decreased expression of RAD18 protein Acetylcysteine inhibits the reaction [4-biphenylamine results in decreased expression of RAD18 protein] |
CTD |
PMID:24857880 PMID:32433928 |
|
NCBI chr 4:145,735,654...145,821,102
Ensembl chr 4:145,735,654...145,821,069
|
|
G |
Rad51 |
RAD51 recombinase |
decreases expression multiple interactions |
ISO |
4-biphenylamine results in decreased expression of RAD51 mRNA; 4-biphenylamine results in decreased expression of RAD51 protein Propolis inhibits the reaction [4-biphenylamine results in decreased expression of RAD51 protein]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of RAD51 mRNA] |
CTD |
PMID:24857880 PMID:32905825 PMID:33847444 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Rad54b |
RAD54 homolog B |
multiple interactions decreases expression |
ISO |
TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of RAD54B mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr 5:25,032,112...25,104,630
Ensembl chr 5:25,032,066...25,104,616
|
|
G |
Rpa1 |
replication protein A1 |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of RPA1 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
|
|
G |
Rpa2 |
replication protein A2 |
multiple interactions increases expression |
ISO |
TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of RPA2 mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr 5:144,976,789...144,989,445
Ensembl chr 5:144,976,748...144,987,350
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
multiple interactions decreases expression |
ISO |
TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of RRM2 mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
multiple interactions |
ISO |
4-biphenylamine inhibits the reaction [SLC22A1 protein results in increased import of Tetraethylammonium] |
CTD |
PMID:27450509 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
multiple interactions |
ISO |
4-biphenylamine inhibits the reaction [SULT1A1 protein results in increased sulfation of Estradiol] |
CTD |
PMID:17433394 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Tp53 |
tumor protein p53 |
affects response to substance multiple interactions decreases expression affects expression affects binding |
ISO |
TP53 protein affects the susceptibility to 4-biphenylamine Acetylcysteine affects the reaction [4-biphenylamine affects the expression of TP53 protein]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of BLM mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of BRCA1 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of BRCC3 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of CCND3 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of CCNE2 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of CDK1 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of CDK2 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of FEN1 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of HDAC2 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of POLD3 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of PRKDC mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of RAD51 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of RAD54B mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of RRM2 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of XRCC5 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of XRCC6 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of CDKN1A mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of H2AX protein]; TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of LIG4 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of MDM2 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of RPA2 mRNA]; TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of TP53BP1 mRNA] 4-biphenylamine results in decreased expression of TP53 mRNA 4-biphenylamine binds to TP53 gene |
CTD |
PMID:11804609 PMID:12376482 PMID:32905825 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53bp1 |
tumor protein p53 binding protein 1 |
multiple interactions increases expression |
ISO |
TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of TP53BP1 mRNA] |
CTD |
PMID:32905825 |
|
NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822
|
|
G |
Tp73 |
tumor protein p73 |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of TP73 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
|
|
G |
Trex1 |
three prime repair exonuclease 1 |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of TREX1 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 8:109,706,613...109,707,913
Ensembl chr 8:109,706,613...109,708,796
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
increases glucuronidation multiple interactions |
ISO |
UGT1A4 protein results in increased glucuronidation of 4-biphenylamine [Alamethicin results in increased activity of UGT1A4 protein] which results in increased glucuronidation of 4-biphenylamine; hecogenin inhibits the reaction [UGT1A4 protein binds to and results in increased glucuronidation of 4-biphenylamine]; UGT1A4 protein binds to and results in increased glucuronidation of 4-biphenylamine |
CTD |
PMID:15840509 PMID:17080401 |
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation multiple interactions |
ISO |
UGT1A9 protein results in increased glucuronidation of 4-biphenylamine [Alamethicin results in increased activity of UGT1A9 protein] which affects the glucuronidation of 4-biphenylamine |
CTD |
PMID:15840509 PMID:17080401 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ung |
uracil-DNA glycosylase |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of UNG mRNA |
CTD |
PMID:24857880 |
|
NCBI chr12:42,485,276...42,494,217
Ensembl chr12:42,485,276...42,494,206
|
|
G |
Xrcc2 |
X-ray repair cross complementing 2 |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of XRCC2 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 4:9,423,873...9,502,980
Ensembl chr 4:9,423,898...9,442,482
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
decreases expression |
ISO |
4-biphenylamine results in decreased expression of XRCC3 mRNA |
CTD |
PMID:24857880 |
|
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
|
|
G |
Xrcc5 |
X-ray repair cross complementing 5 |
multiple interactions decreases expression |
ISO |
Propolis inhibits the reaction [4-biphenylamine results in decreased expression of XRCC5 protein]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of XRCC5 mRNA] 4-biphenylamine results in decreased expression of XRCC5 mRNA; 4-biphenylamine results in decreased expression of XRCC5 protein |
CTD |
PMID:32905825 PMID:33847444 |
|
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
|
|
G |
Xrcc6 |
X-ray repair cross complementing 6 |
multiple interactions decreases expression |
ISO |
Propolis inhibits the reaction [4-biphenylamine results in decreased expression of XRCC6 protein]; TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of XRCC6 mRNA] 4-biphenylamine results in decreased expression of XRCC6 mRNA; 4-biphenylamine results in decreased expression of XRCC6 protein |
CTD |
PMID:32905825 PMID:33847444 |
|
NCBI chr 7:113,542,992...113,563,762
Ensembl chr 7:113,543,057...113,563,762
|
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of ACTA1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of AKR1B7 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases activity |
ISO |
Flurbiprofen results in decreased activity of AKR1C1 protein |
CTD |
PMID:19010312 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
decreases activity |
ISO |
Flurbiprofen results in decreased activity of AKR1C2 protein |
CTD |
PMID:19010312 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
multiple interactions decreases activity |
ISO |
[Flurbiprofen results in decreased activity of AKR1C3 protein] which results in increased chemical synthesis of farnesoic acid; [Flurbiprofen results in decreased activity of AKR1C3 protein] which results in increased metabolism of Farnesol |
CTD |
PMID:19010312 PMID:21187079 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
[Flurbiprofen results in increased phosphorylation of and results in increased activity of PSCA protein] which results in increased expression of AKT1 protein; Akt-I-1,2 compound inhibits the reaction [Flurbiprofen results in increased phosphorylation of and results in increased activity of AKT1 protein]; AKT1 protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA]; Flurbiprofen results in increased phosphorylation of and results in increased activity of AKT1 protein |
CTD |
PMID:16949054 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Flurbiprofen binds to ALB protein |
CTD |
PMID:9353694 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of ALDH7A1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
|
|
G |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
increases expression |
ISO |
Flurbiprofen results in increased expression of ANP32A mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
ISO |
Flurbiprofen results in increased expression of ANXA1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa3 |
annexin A3 |
increases expression |
ISO |
Flurbiprofen results in increased expression of ANXA3 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Apod |
apolipoprotein D |
increases expression |
ISO |
Flurbiprofen results in increased expression of APOD mRNA |
CTD |
PMID:16949054 |
|
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
Apof |
apolipoprotein F |
increases expression |
ISO |
Flurbiprofen results in increased expression of APOF mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 7:700,688...702,130
Ensembl chr 7:700,762...701,946
|
|
G |
App |
amyloid beta precursor protein |
affects cleavage multiple interactions decreases secretion |
ISO EXP |
Flurbiprofen affects the cleavage of APP protein Flurbiprofen inhibits the reaction [APP protein results in increased uptake of Calcium] alitretinoin inhibits the reaction [Flurbiprofen results in decreased secretion of APP protein]; Flurbiprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of APP protein]; RXRA protein promotes the reaction [Flurbiprofen results in decreased secretion of APP protein] |
CTD |
PMID:14690522 PMID:17292621 PMID:18648507 PMID:19659691 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of ARG1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Asic1 |
acid sensing ion channel subunit 1 |
decreases activity |
EXP |
Flurbiprofen results in decreased activity of ASIC1 protein |
CTD |
PMID:11588175 |
|
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression |
ISO |
Flurbiprofen results in increased expression of BIRC5 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
increases expression |
ISO |
Flurbiprofen results in increased expression of BNIP3 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions |
EXP |
Dinoprostone inhibits the reaction [Flurbiprofen inhibits the reaction [Histamine results in increased secretion of CALCA protein]]; Dinoprostone inhibits the reaction [Flurbiprofen inhibits the reaction [Serotonin results in increased secretion of CALCA protein]]; Flurbiprofen inhibits the reaction [[KNG1 protein co-treated with Serotonin co-treated with Histamine] results in increased secretion of CALCA protein]; Flurbiprofen inhibits the reaction [Adenosine Triphosphate promotes the reaction [Protons results in increased secretion of CALCA protein]]; Flurbiprofen inhibits the reaction [CALCA protein results in increased susceptibility to Nitroprusside]; Flurbiprofen inhibits the reaction [Histamine promotes the reaction [[KNG1 protein co-treated with Serotonin] results in increased secretion of CALCA protein]]; Flurbiprofen inhibits the reaction [Histamine results in increased secretion of CALCA protein]; Flurbiprofen inhibits the reaction [Serotonin results in increased secretion of CALCA protein] |
CTD |
PMID:8581270 PMID:11166334 PMID:12044622 PMID:12791437 PMID:14991081 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of CCNB1 protein |
CTD |
PMID:11687965 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
increases expression |
ISO |
Flurbiprofen results in increased expression of CEACAM1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Ces3a |
carboxylesterase 3a |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of CES3 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of CITED2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Cmas |
cytidine monophosphate N-acetylneuraminic acid synthetase |
increases expression |
ISO |
Flurbiprofen results in increased expression of CMAS mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 4:175,718,808...175,737,128
Ensembl chr 4:175,718,808...175,737,125
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of CMPK2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
|
|
G |
Crisp1 |
cysteine-rich secretory protein 1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of CRISP1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 9:20,741,775...20,768,796
Ensembl chr 9:20,741,777...20,768,796
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases activity |
ISO EXP |
Flurbiprofen results in decreased activity of CYP17A1 protein |
CTD |
PMID:31184881 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of CYP24A1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
increases expression |
ISO |
Flurbiprofen results in increased expression of CYP2F2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Defb1 |
defensin beta 1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of DEFB1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
|
|
G |
Egf |
epidermal growth factor |
increases expression |
ISO |
Flurbiprofen results in increased expression of EGF mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
increases phosphorylation multiple interactions |
ISO |
Flurbiprofen results in increased phosphorylation of EIF4E protein MAPK14 protein promotes the reaction [Flurbiprofen results in increased phosphorylation of EIF4E protein] |
CTD |
PMID:18056468 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Elavl1 |
ELAV like RNA binding protein 1 |
multiple interactions increases expression |
ISO |
ELAVL1 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; Flurbiprofen promotes the reaction [ELAVL1 protein binds to NGFR mRNA] Flurbiprofen results in increased expression of ELAVL1 protein |
CTD |
PMID:18056468 |
|
NCBI chr12:2,640,936...2,684,787
Ensembl chr12:2,645,061...2,684,784
|
|
G |
Eln |
elastin |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of ELN mRNA |
CTD |
PMID:16949054 |
|
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of ENPP2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Faah |
fatty acid amide hydrolase |
decreases activity |
EXP |
Flurbiprofen results in decreased activity of FAAH protein |
CTD |
PMID:12751821 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Folr1 |
folate receptor alpha |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of FOLR1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP ISO |
Flurbiprofen inhibits the reaction [Carrageenan results in increased expression of FOS protein]; Flurbiprofen promotes the reaction [Urethane inhibits the reaction [Carrageenan results in increased expression of FOS protein]]; Urethane inhibits the reaction [Flurbiprofen inhibits the reaction [Carrageenan results in increased expression of FOS protein]] Flurbiprofen inhibits the reaction [Arachidonic Acid results in increased expression of FOS mRNA] |
CTD |
PMID:10864209 PMID:11164833 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression multiple interactions |
ISO |
Flurbiprofen results in increased expression of GDF15 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Flurbiprofen results in increased expression of GDF15 protein]; MAPK14 protein promotes the reaction [Flurbiprofen results in increased expression of GDF15 protein]; NGFR protein promotes the reaction [Flurbiprofen results in increased expression of GDF15 protein] |
CTD |
PMID:21097678 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of GPX3 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
increases expression |
ISO |
Flurbiprofen results in increased expression of GSTO1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
|
|
G |
Gusb |
glucuronidase, beta |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [Misonidazole results in increased activity of GUSB protein] |
CTD |
PMID:6696821 |
|
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
|
|
G |
Hells |
helicase, lymphoid specific |
increases expression |
ISO |
Flurbiprofen results in increased expression of HELLS mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
decreases degradation increases expression multiple interactions increases activity |
ISO |
Flurbiprofen results in decreased degradation of HPGD protein Flurbiprofen results in increased expression of HPGD mRNA [[Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA] which results in decreased degradation of HPGD protein Flurbiprofen results in increased activity of HPGD protein |
CTD |
PMID:19501039 |
|
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
ISO |
HRAS protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA] |
CTD |
PMID:16949054 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of HSD11B2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
EXP |
Flurbiprofen results in increased expression of ICAM1 protein |
CTD |
PMID:16020654 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of IFIT2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of APP protein] |
CTD |
PMID:19659691 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Flurbiprofen analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] |
CTD |
PMID:10903797 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il11 |
interleukin 11 |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [IL11 protein results in increased abundance of Calcium]; Flurbiprofen inhibits the reaction [IL11 protein results in increased abundance of Dinoprostone] |
CTD |
PMID:12110441 |
|
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO |
Flurbiprofen inhibits the reaction [[IL1B protein results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Flurbiprofen inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]; Flurbiprofen promotes the reaction [IL1B protein results in increased expression of PTGS2 mRNA] Flurbiprofen results in increased expression of [IL1B protein results in increased expression of PTGS2 protein] |
CTD |
PMID:11112151 PMID:12517972 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Flurbiprofen analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] |
CTD |
PMID:10903797 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kcnn4 |
potassium calcium-activated channel subfamily N member 4 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of KCNN4 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
|
|
G |
Kng1 |
kininogen 1 |
multiple interactions |
EXP |
Flurbiprofen inhibits the reaction [[KNG1 protein co-treated with Serotonin co-treated with Histamine] results in increased abundance of Dinoprostone]; Flurbiprofen inhibits the reaction [[KNG1 protein co-treated with Serotonin co-treated with Histamine] results in increased secretion of CALCA protein]; Flurbiprofen inhibits the reaction [[Serotonin co-treated with Histamine] promotes the reaction [KNG1 protein results in increased abundance of Dinoprostone]]; Flurbiprofen inhibits the reaction [Histamine promotes the reaction [[KNG1 protein co-treated with Serotonin] results in increased secretion of CALCA protein]] |
CTD |
PMID:11166334 PMID:12791437 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Lgals3 |
galectin 3 |
increases expression |
ISO |
Flurbiprofen results in increased expression of LGALS3 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Lgals9 |
galectin 9 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of LGALS9 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
EXP |
Flurbiprofen inhibits the reaction [LHB protein results in increased chemical synthesis of Androstane-3,17-diol]; Flurbiprofen inhibits the reaction [LHB protein results in increased chemical synthesis of Testosterone] |
CTD |
PMID:31184881 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
decreases expression |
EXP |
Flurbiprofen results in decreased expression of LHCGR mRNA; Flurbiprofen results in decreased expression of LHCGR protein |
CTD |
PMID:31184881 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Lmo7 |
LIM domain 7 |
increases expression |
ISO |
Flurbiprofen results in increased expression of LMO7 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr15:78,566,999...78,769,833
Ensembl chr15:78,567,023...78,769,783
|
|
G |
Lto1 |
LTO1 maturation factor of ABCE1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of LTO1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:200,074,247...200,080,951
Ensembl chr 1:200,074,253...200,088,061
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Flurbiprofen results in decreased phosphorylation of and results in decreased activity of MAPK1 protein |
CTD |
PMID:19501039 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk11 |
mitogen-activated protein kinase 11 |
multiple interactions |
ISO |
MAPK11 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein] |
CTD |
PMID:18056468 |
|
NCBI chr 7:120,218,471...120,225,488
Ensembl chr 7:120,218,478...120,225,395
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
MAPK14 protein promotes the reaction [Flurbiprofen results in increased expression of GDF15 protein]; MAPK14 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; MAPK14 protein promotes the reaction [Flurbiprofen results in increased phosphorylation of EIF4E protein] |
CTD |
PMID:18056468 PMID:21097678 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Flurbiprofen results in decreased phosphorylation of and results in decreased activity of MAPK3 protein |
CTD |
PMID:19501039 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapkapk2 |
MAPK activated protein kinase 2 |
multiple interactions |
ISO |
Flurbiprofen results in increased phosphorylation of and results in increased activity of MAPKAPK2 protein; MAPKAPK2 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein] |
CTD |
PMID:18056468 |
|
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
|
|
G |
Mapkapk3 |
MAPK activated protein kinase 3 |
multiple interactions |
ISO |
MAPKAPK3 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein] |
CTD |
PMID:18056468 |
|
NCBI chr 8:107,929,754...107,963,638
Ensembl chr 8:107,929,762...107,963,568
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
[[Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA] which results in decreased degradation of HPGD protein; [Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA Flurbiprofen results in decreased expression of MMP9 mRNA |
CTD |
PMID:19501039 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Msmb |
microseminoprotein, beta |
increases expression |
ISO |
Flurbiprofen results in increased expression of MSMB mRNA |
CTD |
PMID:16949054 |
|
NCBI chr16:7,366,536...7,387,124
Ensembl chr16:7,366,536...7,387,123
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] |
CTD |
PMID:11099482 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbiz |
NFKB inhibitor zeta |
increases expression |
ISO |
Flurbiprofen results in increased expression of NFKBIZ mRNA |
CTD |
PMID:16949054 |
|
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
|
|
G |
Ngfr |
nerve growth factor receptor |
multiple interactions increases expression |
ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Flurbiprofen results in increased expression of NGFR mRNA]; ELAVL1 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; Flurbiprofen promotes the reaction [ELAVL1 protein binds to NGFR mRNA]; Flurbiprofen results in increased stability of and results in increased expression of NGFR mRNA; MAPK11 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; MAPK14 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; MAPKAPK2 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; MAPKAPK3 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; NGFR protein promotes the reaction [Flurbiprofen results in increased expression of GDF15 protein] Flurbiprofen results in increased expression of NGFR mRNA; Flurbiprofen results in increased expression of NGFR protein |
CTD |
PMID:17409433 PMID:17447067 PMID:18056468 PMID:21097678 |
|
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
EXP ISO |
Flurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] Flurbiprofen results in increased expression of NOS2 mRNA Flurbiprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitrites]; Flurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] |
CTD |
PMID:8528547 PMID:11405284 PMID:16944022 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity |
ISO |
Flurbiprofen results in increased activity of NQO1 protein |
CTD |
PMID:8572925 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of PAPSS2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
|
|
G |
Pcp4 |
Purkinje cell protein 4 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of PCP4 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr11:35,759,711...35,861,725
Ensembl chr11:35,800,713...35,861,725
|
|
G |
Pdzk1 |
PDZ domain containing 1 |
increases expression |
ISO |
Flurbiprofen results in increased expression of PDZK1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 2:184,376,161...184,407,514
Ensembl chr 2:184,376,161...184,407,514
|
|
G |
Penk |
proenkephalin |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of PENK mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
|
|
G |
Pik3c3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
increases expression |
ISO |
Flurbiprofen results in increased expression of PIK3C3 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr18:21,845,282...21,934,387
Ensembl chr18:21,845,295...21,929,048
|
|
G |
Pla2g4a |
phospholipase A2 group 4A |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [Arachidonic Acid results in increased expression of PLA2G4A mRNA] |
CTD |
PMID:15878913 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Psca |
prostate stem cell antigen |
multiple interactions increases expression |
ISO |
[Flurbiprofen results in increased phosphorylation of and results in increased activity of PSCA protein] which results in increased expression of AKT1 protein; Akt-I-1,2 compound inhibits the reaction [Flurbiprofen results in increased expression of PSCA protein]; AKT1 protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA]; HRAS protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA] |
CTD |
PMID:16949054 |
|
NCBI chr 7:106,598,203...106,603,114
Ensembl chr 7:106,595,284...106,609,746
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
decreases activity |
ISO EXP |
Flurbiprofen results in decreased activity of PTGS1 protein |
CTD |
PMID:9233713 PMID:9258749 PMID:18848576 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases activity decreases degradation increases expression decreases expression |
EXP ISO |
Flurbiprofen inhibits the reaction [Zymosan results in increased expression of PTGS2 mRNA]; Flurbiprofen inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] Flurbiprofen results in decreased activity of PTGS2 protein Flurbiprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone] Flurbiprofen results in decreased degradation of PTGS2 protein; Flurbiprofen results in decreased degradation of PTGS2 protein mutant form Flurbiprofen results in decreased activity of PTGS2 protein; Flurbiprofen results in decreased activity of PTGS2 protein mutant form Flurbiprofen results in increased expression of [IL1B protein results in increased expression of PTGS2 protein]; Flurbiprofen results in increased expression of PTGS2 mRNA; Flurbiprofen results in increased expression of PTGS2 protein Flurbiprofen inhibits the reaction [16,16-Dimethylprostaglandin E2 results in increased expression of PTGS2 mRNA]; Flurbiprofen inhibits the reaction [[IL1B protein results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Flurbiprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone]; Flurbiprofen inhibits the reaction [Arachidonic Acid results in increased expression of PTGS2 mRNA]; Flurbiprofen inhibits the reaction [Dinoprostone results in increased expression of PTGS2 mRNA]; Flurbiprofen inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]; Flurbiprofen promotes the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Flurbiprofen results in increased expression of and results in increased activity of PTGS2 protein Flurbiprofen results in decreased expression of PTGS2 mRNA |
CTD |
PMID:9099957 PMID:9258749 PMID:9321948 PMID:10594327 PMID:11095985 PMID:11099482 PMID:11112151 PMID:11405284 PMID:11687965 PMID:12517972 PMID:15878913 PMID:16949054 PMID:18848576 PMID:19758985 PMID:22245433 More...
|
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO EXP |
Flurbiprofen inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]; Flurbiprofen inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] Flurbiprofen inhibits the reaction [Zymosan results in increased localization of and results in increased activity of RELA protein] |
CTD |
PMID:11099482 PMID:11291649 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rhog |
ras homolog family member G |
increases expression |
ISO |
Flurbiprofen results in increased expression of RHOG mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:156,618,713...156,630,710
Ensembl chr 1:156,615,349...156,631,257
|
|
G |
Rhou |
ras homolog family member U |
increases expression |
ISO |
Flurbiprofen results in increased expression of RHOU mRNA |
CTD |
PMID:16949054 |
|
NCBI chr19:51,641,476...51,651,249
Ensembl chr19:51,641,227...51,650,552
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [alitretinoin binds to RXRA protein]; RXRA protein promotes the reaction [Flurbiprofen results in decreased secretion of APP protein] |
CTD |
PMID:19659691 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Sell |
selectin L |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of SELL protein |
CTD |
PMID:12147693 |
|
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
|
|
G |
Smoc2 |
SPARC related modular calcium binding 2 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of SMOC2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:55,262,472...55,391,804
Ensembl chr 1:55,262,530...55,391,693
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of SOX2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Sprr2a |
small proline rich protein 2A |
increases expression |
ISO |
Flurbiprofen results in increased expression of SPRR2A mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 2:177,815,964...177,816,236
Ensembl chr 2:177,815,964...177,816,236
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
decreases expression |
EXP |
Flurbiprofen results in decreased expression of SRD5A1 mRNA; Flurbiprofen results in decreased expression of SRD5A1 protein |
CTD |
PMID:31184881 |
|
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Tgoln2 |
trans-golgi network protein 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of TGOLN2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164
|
|
G |
Thrsp |
thyroid hormone responsive |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [Arachidonic Acid results in decreased expression of THRSP mRNA] |
CTD |
PMID:10357836 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression multiple interactions |
ISO |
Flurbiprofen results in increased expression of TIMP1 protein [[Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA] which results in decreased degradation of HPGD protein; [Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA |
CTD |
PMID:19501039 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Flurbiprofen analog promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Flurbiprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of APP protein] |
CTD |
PMID:10903797 PMID:19659691 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases response to substance decreases response to substance increases expression |
ISO |
Flurbiprofen results in increased abundance of and results in increased phosphorylation of TP53 protein TP53 protein results in increased susceptibility to Flurbiprofen TP53 protein mutant form results in decreased susceptibility to Flurbiprofen Flurbiprofen results in increased expression of TP53 protein |
CTD |
PMID:11687965 PMID:15710360 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Twist1 |
twist family bHLH transcription factor 1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of TWIST1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 6:50,674,910...50,676,904
Ensembl chr 6:50,674,678...50,677,653
|
|
G |
Tyms |
thymidylate synthetase |
increases expression |
ISO |
Flurbiprofen results in increased expression of TYMS mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
ISO |
UGT1A1 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15843492 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
increases glucuronidation |
ISO |
UGT1A3 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15117964 PMID:15843492 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
increases glucuronidation |
ISO |
UGT1A4 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15843492 |
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
increases glucuronidation |
ISO |
UGT1A6 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15843492 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15843492 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
increases glucuronidation |
EXP |
UGT2B1 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:8302279 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
increases glucuronidation |
ISO |
UGT2B7 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15843492 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
|
G |
Nat1 |
N-acetyltransferase 1 |
decreases activity |
ISO |
N-hydroxy-4-acetylaminobiphenyl results in decreased activity of NAT1 protein |
CTD |
PMID:15720122 |
|
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Nat2 |
N-acetyltransferase 2 |
decreases activity |
ISO |
N-hydroxy-4-acetylaminobiphenyl results in decreased activity of NAT2 protein |
CTD |
PMID:19842618 |
|
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
|
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
ISO |
[N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of HRAS gene |
CTD |
PMID:11275476 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Nat2 |
N-acetyltransferase 2 |
increases metabolic processing |
ISO |
NAT2 protein results in increased metabolism of N-hydroxy-4-aminobiphenyl |
CTD |
PMID:16857729 |
|
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
multiple interactions increases sulfation |
ISO |
N-hydroxy-4-aminobiphenyl inhibits the reaction [SULT1A1 protein results in increased sulfation of Estradiol] SULT1A1 protein results in increased sulfation of N-hydroxy-4-aminobiphenyl |
CTD |
PMID:17433394 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Sult1c2a |
sulfotransferase family 1C member 2A |
increases sulfation |
ISO |
SULT1C2 protein results in increased sulfation of N-hydroxy-4-aminobiphenyl |
CTD |
PMID:17433394 |
|
NCBI chr 9:6,873,697...6,904,736
Ensembl chr 9:6,874,249...6,904,734
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
[N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of TP53 gene |
CTD |
PMID:11275476 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Casp1 |
caspase 1 |
decreases expression |
ISO |
nitroflurbiprofen results in decreased expression of CASP1 mRNA |
CTD |
PMID:15081244 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Cth |
cystathionine gamma-lyase |
multiple interactions |
EXP |
nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of CTH mRNA] |
CTD |
PMID:16491094 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] |
CTD |
PMID:16491094 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased activity of MPO protein] |
CTD |
PMID:16491094 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression multiple interactions |
ISO EXP |
nitroflurbiprofen results in decreased expression of NOS2 mRNA nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] |
CTD |
PMID:8528547 PMID:15081244 PMID:16491094 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions decreases activity |
ISO EXP |
nitroflurbiprofen inhibits the reaction [TNF protein results in increased activity of RELA protein] nitroflurbiprofen results in decreased activity of RELA protein nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein] |
CTD |
PMID:12716482 PMID:16491094 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
nitroflurbiprofen inhibits the reaction [TNF protein results in increased activity of RELA protein] nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] |
CTD |
PMID:12716482 PMID:16491094 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|